Founded in 1972, Sofinnova Partners is a European venture capital firm based in Paris, London, and Milan, focusing on life sciences investments across healthcare and sustainability sectors. With over €4 billion in assets under management, the firm has backed more than 500 companies over 50 years, creating market leaders globally. Sofinnova Partners operates seven investment strategies, covering the entire value chain from seed to later-stage investments, including biopharma, medtech, industrial biotech, and digital medicine.
Is Sofinnova Partners the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Sofinnova Partners, along with a list of other relevant VCs, is available on Hopohopo.io.
Investment role
Lead and follow
Stages
Seed, Series A, Series B or later
First ticket size
€7,500,000 - €75,000,000
When approaching Sofinnova Partners, founders should highlight breakthrough science, robust clinical or technical validation, and a clear path to market leadership. Demonstrate how your team’s expertise and vision can drive transformative impact in healthcare or sustainability, and be prepared to discuss regulatory, reimbursement, and commercialization strategies. Emphasize your ability to scale and attract top-tier partners, as Sofinnova values teams with both scientific depth and commercial acumen.
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.